dwuuuu,
Why would NAB want the deal to proceed? I see two major issues from an institutional perspective:
1. The deal as it stands undervalues the asset. They are capable of comparing transaction and trading multiples.
2. Institutional investors are smart enough to understand that an asset sale is a poor outcome relative to a takeover of the entire company. They will have no interest in holding shares of a thinly traded cash box. They understand that a dollar in their hands is worth a dollar, yet a dollar in the post sale company will be worth at maximum 80 cents.
If you believe otherwise, I suggest you start loading up on the stock. At 25.5 cents, you clearly will be the only one doing so.
The price action seems to be indicative of a deal that will be voted down.
- Forums
- ASX - By Stock
- CHN
- so where are we actually at?
so where are we actually at?, page-13
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.35 |
Change
-0.010(0.74%) |
Mkt cap ! $571.8M |
Open | High | Low | Value | Volume |
$1.37 | $1.37 | $1.35 | $423.5K | 312.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 127784 | $1.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.35 | 37038 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 386752 | 0.145 |
6 | 299000 | 0.140 |
8 | 191611 | 0.135 |
6 | 319853 | 0.130 |
5 | 292000 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 40000 | 2 |
0.155 | 367180 | 1 |
0.160 | 460998 | 10 |
0.165 | 353140 | 7 |
0.170 | 248919 | 2 |
Last trade - 11.00am 25/11/2024 (20 minute delay) ? |
Featured News
CHN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online